These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17540022)

  • 1. Psychometric properties of a prostate cancer radiation late toxicity questionnaire.
    Rodrigues G; Bauman G; Lock M; D'Souza D; Mahon J
    Health Qual Life Outcomes; 2007 May; 5():29. PubMed ID: 17540022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
    Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
    Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life of men treated with brachytherapies for prostate cancer.
    Lev EL; Eller LS; Gejerman G; Lane P; Owen SV; White M; Nganga N
    Health Qual Life Outcomes; 2004 Jun; 2():28. PubMed ID: 15198803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health-related quality of life in patients with spinal metastases.
    Versteeg AL; Sahgal A; Rhines LD; Sciubba DM; Schuster JM; Weber MH; Varga PP; Boriani S; Bettegowda C; Fehlings MG; Clarke MJ; Arnold PM; Gokaslan ZL; Fisher CG;
    Cancer; 2018 Apr; 124(8):1828-1838. PubMed ID: 29409108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancer.
    Yoshida K; Yamazaki H; Nakamara S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Yoshioka Y
    Anticancer Res; 2014 Apr; 34(4):2015-8. PubMed ID: 24692740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
    Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
    Flood EM; Beusterien KM; Green H; Shikiar R; Baran RW; Amonkar MM; Cella D
    Health Qual Life Outcomes; 2006 Jul; 4():42. PubMed ID: 16834773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis.
    Zilli T; Taussky D; Donath D; Le HP; Larouche RX; Béliveau-Nadeau D; Hervieux Y; Delouya G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e377-83. PubMed ID: 21514068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
    Downs TM; Sadetsky N; Pasta DJ; Grossfeld GD; Kane CJ; Mehta SS; Carroll PR; Lubeck DP
    J Urol; 2003 Nov; 170(5):1822-7. PubMed ID: 14532784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
    Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
    Bergman J; Saigal CS; Kwan L; Litwin MS
    Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population.
    Abetz L; Arbuckle R; Allen RP; Mavraki E; Kirsch J
    Health Qual Life Outcomes; 2005 Dec; 3():79. PubMed ID: 16329756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
    Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
    J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial personal digital assistant data capture of health-related quality of life: a randomized controlled trial in a prostate cancer clinic.
    Matthew AG; Currie KL; Irvine J; Ritvo P; Santa Mina D; Jamnicky L; Nam R; Trachtenberg J
    Health Qual Life Outcomes; 2007 Jul; 5():38. PubMed ID: 17617906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
    Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.